 | Up a level |
Siegenthaler, F; Lindemann, K; Epstein, E; Rau, T T; Nastic, D; Ghaderi, M; Rydberg, F; Mueller, M D; Carlson, J; Imboden, S (2022). Time to first recurrence, pattern of recurrence, and survival after recurrence in endometrial cancer according to the molecular classification. Gynecologic oncology, 165(2), pp. 230-238. Elsevier 10.1016/j.ygyno.2022.02.024
Eriksson, L S E; Nastic, D; Lindqvist, P G; Imboden, S; JÄrnbert-Pettersson, H; Carlson, J W; Epstein, E (2021). Sonographic, demographic characteristics, and the Proactive Molecular Risk Classifier for Endometrial cancer (ProMisE) in the prediction of tumor recurrence or progression. Ultrasound in obstetrics & gynecology, 58(3), pp. 457-468. Wiley InterScience 10.1002/uog.23573
